Squamous Cell Carcinoma of Unknown Primary Origin
1 clinical trials · Condition
◉ Watch Squamous Cell Carcinoma of Unknown Primary Origin
| Record | Firm | Date |
|---|---|---|
| Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536) | University of Arizona | 2017-12-05 |
Track Squamous Cell Carcinoma of Unknown Primary Origin automatically
Every clearance here is in the API, with alerts when new ones post.